Fact check
“Beginning in 1992, the DEA defined "accepted medical use" based on five criteria, including "adequate safety studies" and "adequate and well-controlled studies proving efficacy."”
Reasoning
The provided evidence from Reason.com cites a GAO report that explicitly mentions the DEA's 1992 definition of "accepted medical use" with the specified criteria. No contradictory information is presented.
On confidence: The claim is directly corroborated by a primary source excerpt stating that the DEA defined "accepted medical use" in 1992 based on five criteria, including "adequate safety studies" and "adequate and well-controlled studies proving efficacy."
Important context
The definition pertains to the DEA's criteria for scheduling drugs under the Controlled Substances Act, as reported in a 2026 article referencing a GAO report.
Evidence
Supporting (2)
- Tier 1 — Primary sourceFederal drug scheduling relies on vague criteria, GAO report finds
cannabis illustrates that puzzle. When Congress enacted the CSA in 1970, it placed marijuana in Schedule I, and the Drug Enforcement Administration (DEA), which had the authority to reclassify drugs in consultation with the Department of…
- Tier 1 — Primary sourceFederal drug scheduling relies on vague criteria, GAO report finds
Drug Policy Hazy Drug Classification Criteria Invite Dubious Bureaucratic Judgments A GAO report notes that the Controlled Substances Act does not define "potential for abuse" or "accepted medical use." Jacob Sullum | 9.30.2026 12:01 AM…
Limitations
The evidence is limited to a secondary reporting source (Reason.com) summarizing the GAO report; the original GAO document is not directly quoted. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.
- Last verified:
- Oct 1, 2026, 4:49 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
Hazy Drug Classification Criteria Invite Dubious Bureaucratic JudgmentsReason · Jacob Sullum